Terms: = Liver cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck
26 results:
1. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer.
Deng JY; Gou Q; Yang L; Chen ZH; Yang MY; Yang XR; Yan HH; Wei XW; Liu JQ; Su J; Zhong WZ; Xu CR; Wu YL; Zhou Q
J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463790
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Src Family Kinases in Hepatocellular Carcinoma.
Yao D; Deng Y; Zhang S; Liang L; Zhang L; Weng S; Chen S
Front Biosci (Landmark Ed); 2023 May; 28(5):90. PubMed ID: 37258470
[TBL] [Abstract] [Full Text] [Related]
3. Galectin-9 promotes natural killer cells activity
Rahmati A; Bigam S; Elahi S
Front Immunol; 2023; 14():1131379. PubMed ID: 37006235
[TBL] [Abstract] [Full Text] [Related]
4. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
[TBL] [Abstract] [Full Text] [Related]
5. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Hou Y; Zhang G
Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
[TBL] [Abstract] [Full Text] [Related]
6. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
[TBL] [Abstract] [Full Text] [Related]
7. A new clinical prognostic nomogram for liver cancer based on immune score.
Shen Q; Hu G; Wu J; Lv L
PLoS One; 2020; 15(7):e0236622. PubMed ID: 32730361
[TBL] [Abstract] [Full Text] [Related]
8. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
Dong F; Yang Q; Wu Z; Hu X; Shi D; Feng M; Li J; Zhu L; Jiang S; Bao Z
Biomed Pharmacother; 2019 Jun; 114():108856. PubMed ID: 30981109
[TBL] [Abstract] [Full Text] [Related]
9. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract] [Full Text] [Related]
10. Regulation of periostin expression by Notch signaling in hepatocytes and liver cancer cell lines.
Kongkavitoon P; Butta P; Sanpavat A; Bhattarakosol P; Tangtanatakul P; Wongprom B; Tangkijvanich P; Hirankarn N; Palaga T
Biochem Biophys Res Commun; 2018 Nov; 506(3):739-745. PubMed ID: 30384995
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC.
Ji J; Yin Y; Ju H; Xu X; Liu W; Fu Q; Hu J; Zhang X; Sun B
Cell Death Dis; 2018 May; 9(5):478. PubMed ID: 29706626
[TBL] [Abstract] [Full Text] [Related]
12. T-Cell-Specific Deletion of Map3k1 Reveals the Critical Role for Mekk1 and Jnks in Cdkn1b-Dependent Proliferative Expansion.
Suddason T; Anwar S; Charlaftis N; Gallagher E
Cell Rep; 2016 Jan; 14(3):449-457. PubMed ID: 26774476
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune system.
Huang KC; Yang KC; Lin H; Tsao Tsun-Hui T; Lee WK; Lee SA; Kao CY
BMC Genomics; 2013; 14 Suppl 5(Suppl 5):S10. PubMed ID: 24564241
[TBL] [Abstract] [Full Text] [Related]
14. Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma.
Zheng S; Tansey WP; Hiebert SW; Zhao Z
BMC Med Genomics; 2011 Aug; 4():62. PubMed ID: 21824427
[TBL] [Abstract] [Full Text] [Related]
15. A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors.
Pacey S; Wilson RH; Walton M; Eatock MM; Hardcastle A; Zetterlund A; Arkenau HT; Moreno-Farre J; Banerji U; Roels B; Peachey H; Aherne W; de Bono JS; Raynaud F; Workman P; Judson I
Clin Cancer Res; 2011 Mar; 17(6):1561-70. PubMed ID: 21278242
[TBL] [Abstract] [Full Text] [Related]
16. Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.
Berzsenyi MD; Woollard DJ; McLean CA; Preiss S; Perreau VM; Beard MR; Scott Bowden D; Cowie BC; Li S; Mijch AM; Roberts SK
J Hepatol; 2011 Sep; 55(3):536-544. PubMed ID: 21266183
[TBL] [Abstract] [Full Text] [Related]
17. Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes.
Watanabe T; Kobunai T; Yamamoto Y; Kanazawa T; Konishi T; Tanaka T; Matsuda K; Ishihara S; Nozawa K; Eshima K; Muto T; Nagawa H
Eur J Cancer; 2010 Jul; 46(11):2119-26. PubMed ID: 20570135
[TBL] [Abstract] [Full Text] [Related]
18. Histological evaluation of intracapsular venous invasion for discrimination between portal and hepatic venous invasion in hepatocellular carcinoma.
Ohashi M; Wakai T; Korita PV; Ajioka Y; Shirai Y; Hatakeyama K
J Gastroenterol Hepatol; 2010 Jan; 25(1):143-9. PubMed ID: 19968750
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
[TBL] [Abstract] [Full Text] [Related]
20. Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.
Grem JL; Morrison G; Guo XD; Agnew E; Takimoto CH; Thomas R; Szabo E; Grochow L; Grollman F; Hamilton JM; Neckers L; Wilson RH
J Clin Oncol; 2005 Mar; 23(9):1885-93. PubMed ID: 15774780
[TBL] [Abstract] [Full Text] [Related]
[Next]
